PS to myself he he. If $3.00 becomes the base line SP by December before any meaningful roll out of sales, then exponential SP growth going foreward is also reasonable given the size of our target market. Lets hope Richard considers NASDAC ? listing just like Renaltyx, so we see the same kind of explosive share holder value being realised going forward. l am so excited l am trembling.
Ann: Proteomics files US FDA 513(g) regulatory submission, page-34
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
0.005(1.41%) |
Mkt cap ! $58.86M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 35.5¢ | $116.7K | 323.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 13166 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 113491 | 3 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |